Why man who won $289M weedkiller award won't get most of the money
Because of a change in the tax law, man who won massive weedkiller award could end up with much less
Watch CBS News
Because of a change in the tax law, man who won massive weedkiller award could end up with much less
31 out of 45 tested products had glyphosate levels higher than what some scientists consider safe for children
Former groundskeeper won massive award after claiming that exposure to weed killer gave him cancer
"The simple fact is he is going to die," said the attorney who represented Dewayne Johnson, who has non-Hodgkin's lymphoma
Former Northern California school groundskeeper blames his terminal cancer on weed-killer Roundup
The case of a California groundskeeper now stricken with cancer could show how hundreds of others might go
The widely used herbicide is facing a legal threat concerning the question of its potential to cause cancer
CBS News legal analyst Rikki Klieman told "CBS This Morning" that the trial's outcome will serve as a "bellwether" for the thousands that could follow
Surprising nobody, German drug giant confirms combined company will drop politically charged moniker of pesticide maker
A federal judge could decide the fate of more than 300 lawsuits filed against Monsanto by cancer victims
Apple and Monsanto stakes were increased; IBM and Wells Fargo shares were sold -- all while cash pile grew to $100B
The pharmaceutical giant is selling parts of its Crop Science unit to BASF to ease regulatory concern over its Monsanto takeover
California lawmakers took a major step in light of concerns about the popular weed killer Roundup, but Monsanto insists it is safe
In a statement, Monsanto said maintained the product doesn't cause cancer as claimed in lawsuit
State leaders say agrochemical giant hid what it knew about effect of toxic substances on humans and animals
Judiciary Committee Chair Charles Grassley of Iowa fears the deal could punish American farmers with higher costs
Low commodity prices and industry consolidation are among the reasons behind the biggest deal so far this year
German firm says it is paying Monsanto shareholders $128 per share, a 44 percent premium over Monsanto’s closing price on May 9
The German drug company’s sweetened bid now values the U.S. agricultural giant at nearly $56 billion
German healthcare and chemical giant had made $62 billion all-cash bid for U.S. agricultural company
Agrochem giant could draw fire from "Frankenfood" critics, while also needing to pass muster with investors and regulators
Proposed combination would create a giant seed and farm chemical company with a strong presence in the U.S., Europe and Asia
Monsanto, already a lightning rod for criticism, may become part of a bigger seed and chemical company
The giant German and U.S. chemical and agriculture companies are hold private negotiations over a potential merger
Genetically-modified plants can be a boon to farmers (and corporations), but skeptical consumers want more answers about food safety